Cargando…
Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study
Penicillin-binding proteins (PBPs) catalyze the final stages for peptidoglycan cell-wall bio-synthesis. Mutations in the PBP2a subunit can attenuate β-lactam antibiotic activity, resulting in unimpeded cell-wall formation and methicillin-resistant Staphylococcus aureus (MRSA). A double mutation in P...
Autores principales: | Ibrahim, Mahmoud A. A., Abdeljawaad, Khlood A. A., Abdelrahman, Alaa H. M., Alzahrani, Othman R., Alshabrmi, Fahad M., Khalaf, Esraa, Moustafa, Mahmoud F., Alrumaihi, Faris, Allemailem, Khaled S., Soliman, Mahmoud E. S., Paré, Paul W., Hegazy, Mohamed-Elamir F., Atia, Mohamed A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388891/ https://www.ncbi.nlm.nih.gov/pubmed/34438984 http://dx.doi.org/10.3390/antibiotics10080934 |
Ejemplares similares
-
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Chetomin, a SARS-CoV-2 3C-like Protease (3CL(pro)) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
por: Ibrahim, Mahmoud A.A., et al.
Publicado: (2021) -
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022)